Vol. 5, Issue 1, Part A (2023)

Chronic Hepatitis B (HBV) and hepatitis C (HCV) infections are leading causes of liver cirrhosis worldwide. This comparative study aims to evaluate the clinical progression, risk factors, and outcomes of hepatic cirrhosis in patients with chronic HBV and HCV infections. Data from 500 patients, equally divided between HBV and HCV cases, were analyzed for fibrosis staging, complications, and long-term survival outcomes. The study identifies key differences in disease progression, cirrhosis onset, and the efficacy of antiviral therapies. Findings suggest that while both infections lead to cirrhosis, the pathways and outcomes vary significantly between the two groups, with distinct implications for management and treatment strategies.